Q: Could you comment on the JV in China please? If all continues to go well with the kidney drugs, what is a reasonable time frame to give this company for execution of its game plan?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH $65.48)
-
BMO Nasdaq 100 Equity Hedged To CAD Index ETF (ZQQ $161.95)
-
iShares Core MSCI EAFE IMI Index ETF (XEF $44.95)
Q: When would be a good time to make these acquistions?
Q: You have expressed the opinion that investors are bored with GUD as the reason for its recent rather lackluster performance but it's recent dive over the last 3 trading sessions of about 10% seems more than boredom. Is there anything going on at the company with respect to their products or with their management team that could be behind the steady downward pressure on the shares?
Q: Hi Team,
I know Knight is a long-term play. Any thoughts about it's continued, recent weakness. Would you add to a position at the present time (I've held it for a while, was up over 30% and and am now up only 6.5%)? I am willing to be patient.
Thanks, Michael
I know Knight is a long-term play. Any thoughts about it's continued, recent weakness. Would you add to a position at the present time (I've held it for a while, was up over 30% and and am now up only 6.5%)? I am willing to be patient.
Thanks, Michael
Q: Can you plz comment on recent earnings and outlook of the company? Thanks.
Q: Hello,Your comments on SIS Q2 results and the stock price drop, please. SIS met the revenue expectations but the Adj EBITDA, net earnings and Adj EPS all were below expectations. What is your take -to continue to hold or reduce position?
Q: Would appreciate your overview of CHH results, debt and strategic distribution and supply agreement and strategic investment with AceAge. Also, do you think they will end up getting all the McKesson contracts after the acquisition of Rexall? Thanks
Q: Can you please comment on the earnings for Savaria $SIS. Thanks Valter
Q: Good morning,
Could you please comment on GUD's earnings release? Is the market reaction due to impatience like you've said before or is there an other reason? Also, for someone that holds a half position currently at a loss, would now be a good time to add with a longer term time frame in mind?
Thank you!
Could you please comment on GUD's earnings release? Is the market reaction due to impatience like you've said before or is there an other reason? Also, for someone that holds a half position currently at a loss, would now be a good time to add with a longer term time frame in mind?
Thank you!
Q: were knights earnings that bad or are they even relevant, but this stock is just getting hammered day after day. also what is the amount of cash on the balance sheet, i think it is about 6 dollars a share, just confirm please. dave
Q: Hi
I own a 2% position in teva pharmaceuticals. It is down nearly 60%. You have recommended selling the stock in a response to a somular question yesterday. My problem is I am holding this in an RRSP and cannot take advantage of a tax loss. I am comfortable holding for a few years in the hopes of a rebound, collecting the dividend meanwhile. Do you think this is wishful thinking?
Do I cut my losses, or do I wait patiently for a possible recovery?
Thank you
Karim
I own a 2% position in teva pharmaceuticals. It is down nearly 60%. You have recommended selling the stock in a response to a somular question yesterday. My problem is I am holding this in an RRSP and cannot take advantage of a tax loss. I am comfortable holding for a few years in the hopes of a rebound, collecting the dividend meanwhile. Do you think this is wishful thinking?
Do I cut my losses, or do I wait patiently for a possible recovery?
Thank you
Karim
Q: GUD. GUD seems to have reached a turning point today, do you agree ?
Q: why do you say crh has to have management changes , because management missed guidance, lots of companies miss guidance and you do not call for mgmt changes, kinaxis missed guidance, pivot missed guidance the list goes on and on. dave
Q: Hi folks:
hate to beat a dead horse, but do we still hold .Down close to 60 percent at the moment. I bought this for the long run but my goodness this stock is frustrating!
Thank you.
hate to beat a dead horse, but do we still hold .Down close to 60 percent at the moment. I bought this for the long run but my goodness this stock is frustrating!
Thank you.
Q: have you any idea why BIOA has been clobbered today after their eps for the qtr which seemed ok. thanks
Q: Medical Laboratories and medical testing clinics seem largely to be owned by private corporations. Is this correct ? If so, which publicly traded corporations may be positioned to acquire private medical labs or to make other investments in the medical testing field ?
Q: Hi5i, I do not own CRH in my portfolio, is it a buy at this price? Thanks always.
Q: The recent hand wringing (and rightly) over CRH (haven't owned for years) has made me question what rationale retail investors use to buy and sell. I understand why advisors suggest a buy and hold strategy. But can't understand why retail investors need to be tied to that philosophy. I'm making a leap and will assume most members of this site use a discount brokerage. Given the almost insignificant cost to buy and sell (assuming buys and sells of more than $10,000), isn't a more active approach to trading a reasonable proposition? I use technicals to take the emotion out of the equation and would love to know what buy and sell discipline you would suggest. Having personal buy/sell rules might help investors feel better about making these decisions.
Thanks for all your support and advice over the years.
Thanks for all your support and advice over the years.
Q: Hi team, Dermira Inc is a biopharm stock in the US with a few late stage trials going on. Are you able to give me any information regarding the quality of management/leadership team, and general health of the company, and a timeline for when they might start being profitable? Thanks very much.
Q: Please completely dissect earnings released tonight.
Also, do you know how their drug pipeline is coming along?
Also, do you know how their drug pipeline is coming along?